Correction to: Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes

Affiliations

• ¹ The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
• ² Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
• ³ Oregon Health and Science University, Portland, OR, USA.
• ⁴ Miami Itch Center, Miller School of Medicine, University of Miami, Miami, FL, USA.
• ⁵ Center for Chronic Pruritus, University of Münster, Münster, Germany.
• ⁶ Pfizer Inc., New York, NY, USA.
• ⁷ Pfizer Inc., Groton, CT, USA.
• ⁸ Pfizer Inc., Collegeville, PA, USA.
• ⁹ Pfizer Ltd., Surrey, UK.
• ¹⁰ Pfizer Inc., New York, NY, USA. [email protected].